Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 84, Issue 6, Pages 1238-1249
Publisher
Wiley
Online
2018-02-13
DOI
10.1111/bcp.13548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
- (2017) Simon D Harding et al. NUCLEIC ACIDS RESEARCH
- Ofatumumab for the treatment of childhood nephrotic syndrome
- (2017) Chia-Shi Wang et al. PEDIATRIC NEPHROLOGY
- Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
- (2017) Pietro Ravani et al. BMJ Open
- Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment
- (2016) Alice Bonanni et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab
- (2016) Marina Vivarelli et al. PEDIATRIC NEPHROLOGY
- Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis
- (2015) I. Fleury et al. ANNALS OF ONCOLOGY
- Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children
- (2015) P. Ravani et al. Clinical Journal of the American Society of Nephrology
- B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome
- (2015) M. Colucci et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial
- (2015) P. Ravani et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome
- (2015) Alice Bonanni et al. PLoS One
- Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma - a phase II trial
- (2014) Michelle Furtado et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome
- (2014) A. Sinha et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance
- (2014) Joëlle Guitard et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Ofatumumab for Rituximab-Resistant Nephrotic Syndrome
- (2014) Biswanath Basu NEW ENGLAND JOURNAL OF MEDICINE
- Novel Use of Rituximab for Steroid-Dependent Nephrotic Syndrome in Children
- (2013) Takahisa Kimata et al. AMERICAN JOURNAL OF NEPHROLOGY
- Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor–dependent idiopathic nephrotic syndrome
- (2013) Pietro Ravani et al. KIDNEY INTERNATIONAL
- Rituximab in Idiopathic Membranous Nephropathy
- (2012) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome
- (2012) A. Magnasco et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab in immunologic glomerular diseases
- (2012) A. Ahsan Ejaz et al. mAbs
- Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
- (2012) Laëtitia Delbe-Bertin et al. PEDIATRIC NEPHROLOGY
- Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
- (2011) P. C. Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Short-Term Effects of Rituximab in Children with Steroid- and Calcineurin-Dependent Nephrotic Syndrome: A Randomized Controlled Trial
- (2011) P. Ravani et al. Clinical Journal of the American Society of Nephrology
- Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery
- (2011) A.-L. Sellier-Leclerc et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome
- (2011) M. J. Kemper et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma
- (2010) Corrado Tarella et al. JOURNAL OF CLINICAL ONCOLOGY
- Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine
- (2010) Shuichiro Fujinaga et al. PEDIATRIC NEPHROLOGY
- Rituximab efficiency in children with steroid-dependent nephrotic syndrome
- (2010) Anne-Laure Sellier-Leclerc et al. PEDIATRIC NEPHROLOGY
- Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20
- (2009) Jiamu Du et al. MOLECULAR IMMUNOLOGY
- Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children
- (2009) Koichi Kamei et al. PEDIATRIC NEPHROLOGY
- Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases
- (2008) Vincent Guigonis et al. PEDIATRIC NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now